PR Newswire
London, June 18
Notification of major interests in shares
June 18, 2015 - Shire plc (LSE: SHP, NASDAQ: SHPG)
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Shire plc |
| 2. Reason for the notification | State Yes/No |
| An acquisition or disposal of voting rights | Yes |
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | No |
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | No |
| An event changing the breakdown of voting rights | No |
| Other (please specify): | No |
| 3. Full name of person(s) subject to the notification obligation: | FMR LLC |
| 4. Full name of shareholder(s) (if different from 3.): | See Section 9 |
| 5. Date of the transaction (and date on which the threshold is crossed or reached if different): | June 17, 2015 |
| 6. Date on which issuer notified: | June 18, 2015 |
| 7. Threshold(s) that is/are crossed or reached: | 5% |
| 8. Notified details: | ||||||||
| A: Voting rights attached to shares | ||||||||
Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||
| Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights | ||||
| Indirect | Direct | Indirect | Direct | Indirect | ||||
JE00B2QKY057 | 29,674,746 | 29,674,746 | 29,412,481 | 29,412,481 | 4.96 | |||
| B: Qualifying Financial Instruments | ||||
| Resulting situation after the triggering transaction | ||||
| Type of financial instrument | Expiration date | Exercise/Conversion Period/ Date | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||
| Resulting situation after the triggering transaction | ||||||
| Type of financial instrument | Exercise price | Expiration date | Exercise/ Conversion period | Number of voting rights instrument refers to | % of voting rights | |
| Nominal | Delta | |||||
| Total (A+B+C) | |
| Number of voting rights | % of voting rights |
| 29,412,481 | 4.96 |
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
| Proxy Voting: 10. Name of the proxy holder: | FMR LLC |
| 11. Number of voting rights proxy holder will cease to hold: | 262,265 |
| 12. Date on which proxy holder will cease to hold voting rights: | June 17, 2015 |
| 13. Additional information: | None |
| 14. Contact name: | Sally-Ann Hatton |
| 15. Contact telephone number: | fil-regreporting@fil.com, 01737 837148 |
For further information please contact:
| Investor Relations | ||
| Sarah Elton-Farr | seltonfarr@shire.com | +44 1256 894157 |
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.
http://www.shire.com/
